Table 2 Percentage of methylated CpG in tumor vs. normal tissue. Sequence analysis was performed after bisulfite treatment.
From: Epigenetic regulation of RhoB loss of expression in lung cancer
Patients | Tissue | meth CpG |
|---|---|---|
1 | Normal | 2.5% |
Tumor | 4% | |
2 | Normal | 2% |
Tumor | 2.2% | |
3 | Normal | 3% |
Tumor | 4.2% | |
4 | Normal | 5% |
Tumor | 4.3% | |
5 | Normal | 1.5% |
Tumor | 1.8% | |
6 | Normal | 4.9% |
Tumor | 4.8% |